Allopurinol
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Allopurinol and local guidelines before prescribing.
Mechanism
Xanthine oxidase inhibitor reducing uric acid production.
Uses
Gout prevention, tumour lysis prophylaxis, recurrent urate stones.
Dosing
- Azathioprine 2–2.5 mg/kg/day | Maintenance; check TPMT first; FBC and LFT monitoring; pancreatitis, marrow suppression, skin cancer; avoid allopurinol.
Gastroenterology: Inflammatory Bowel Disease - Allopurinol — xanthine oxidase inhibitor — start low (100 mg daily, lower in CKD) and titrate monthly to a target urate under 360 µmol/L (under 300 if tophi or frequent flares); risks — rash, severe cutaneous reactions (SJS/TEN, DRESS — HLA-B*58:01 in Han Chinese, Thai and Korean ancestry); azathioprine and mercaptopurine …
Rheumatology Anatomy Physiology Pharmacology - Allopurinol starting low (e.g. 50–100 mg daily given CKD) and titrating monthly to urate under 360 µmol/L .
Rheumatology Anatomy Physiology Pharmacology - Allopurinol (xanthine oxidase inhibitor) - first-line ; start low (100 mg daily, or lower in CKD) and increase monthly (by 100 mg) according to urate until at target (often 300–600 mg or more; up to 900 mg); check urate monthly while titrating.
Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain
2 more dose entries from the chapters
- Start allopurinol 100 mg daily, increasing by 100 mg every month according to urate (checked monthly) to a target below 360 µmol/L .
Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain - 2. A 62-year-old man started allopurinol 300 mg daily 3 weeks ago for gout. He now has fever, sore red eyes, painful mouth ulcers and dusky skin lesions that are starting to blister on his trunk. Answer: Stevens–Johnson syndrome / toxic epidermal necrolysis.
Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy
Side effects
Rash, GI upset; rarely severe hypersensitivity (HLA-B*58:01), hepatitis, marrow suppression.
Interactions
Azathioprine and mercaptopurine toxicity rises (reduce doses); ampicillin rash more likely.
Contraindications and cautions
HLA-B*5801 carriers at higher risk of severe rash; avoid starting during an acute flare
Monitoring
Urate every few weeks to target below 360 micromol/L, creatinine, LFT, rash
Pregnancy and breastfeeding
Specialist advice
Renal and hepatic impairment
Start low and titrate in renal impairment
Overdose and reversal
Supportive
Special advice
Do not start in an acute attack; start low and titrate with serum urate; cover with colchicine or NSAID when starting; stop at first rash.
More from the textbook: uses, cautions and other points
- Allopurinol blocks xanthine oxidase, which breaks down thiopurines → dangerous toxicity - avoid, or use only with a specialist dose reduction (about a quarter of the dose).
Gastroenterology: Anatomy Physiology Pharmacology - Azathioprine / mercaptopurine | Check TPMT; marrow suppression, pancreatitis, skin cancer; avoid allopurinol.
Gastroenterology: Anatomy Physiology Pharmacology - Interaction: Allopurinol raises thiopurine levels dangerously. It is sometimes used deliberately with a quarter-dose thiopurine, under specialist care only.
Gastroenterology: Inflammatory Bowel Disease - Check TPMT before thiopurines; never combine with allopurinol without specialist dose reduction.
Gastroenterology: Inflammatory Bowel Disease - Mixed | Carbamazepine, phenytoin, sulfonamides, allopurinol
Gastroenterology: Liver disease - Aciclovir (confusion, crystals), baclofen (encephalopathy), colchicine, allopurinol (start low), methotrexate, sotalol, spironolactone (potassium), nitrofurantoin, bisphosphonates.
Renal: Anatomy, Physiology and Pharmacology
Where it is discussed in the book
- Gastroenterology: Anatomy Physiology Pharmacology (7 mentions)
- Gastroenterology: Inflammatory Bowel Disease (3 mentions)
- Gastroenterology: Liver disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (4 mentions)
- Renal: Chronic Kidney Disease (2 mentions)
- Renal: Tubular Inherited Stones (2 mentions)
- Renal: Dialysis and Transplant (5 mentions)
- Haematology: Anatomy Physiology and Pharmacology (5 mentions)
- Haematology: Emergencies (1 mention)
- Haematology: Leukaemias, myeloproliferative neoplasms and myelodysplasia (3 mentions)
- Haematology: Myeloma and Lymphoma (3 mentions)
- Oncology: Emergencies (2 mentions)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (10 mentions)
- Rheumatology Anatomy Physiology Pharmacology (7 mentions)
- Rheumatology: assessment, investigations and drugs (4 mentions)
- Rheumatology: Crystal arthritis, osteoarthritis and soft tissue pain (16 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (1 mention)
- Medicine of the older adult: .Prescribing and deprescribing in older people (4 mentions)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (4 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (9 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Clinical Immunology: Immune system basics and immunological investigations (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (2 mentions)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (4 mentions)
- Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics (1 mention)